Wednesday, August 16, 2017
12:00pm – 1:30pm Eastern time
1.5 CE Credits
||Robin C. Hilsabeck, Ph.D.
Senior Clinical Scientist, INC Research
Clinical Associate Professor, University of Texas – Austin
||David Williamson, Ph.D., M.B.A.
Medical Science Liaison, Janssen Scientific Affairs
Adjunct Associate Professor, University of South Alabama
Clinical trials research is a large industry with multiple players, including pharmaceutical and biotech companies, contract research organizations, clinical research sites, and various vendors who offer specialized services (e.g., rater training, neuroimaging, genetic testing). While neuropsychologists typically do not learn much about clinical trials research during training, neuropsychologists are well-suited for a career within this industry. The purpose of this webinar is to introduce neuropsychologists to the basic terminology and structure of clinical trials research and to review functions and roles of key players. Opportunities for neuropsychologists within clinical trials research settings will be discussed, as well as knowledge and skills that contribute to success in the clinical trials industry and related corporate settings. Avenues for pursuing practice and career opportunities in clinical trials research settings will be provided.
After the webinar, participants will be able to:
- Summarize the four phases of clinical trials research.
- Explain the roles of two key organizational players in clinical trials research.
- Describe three functions of rater training vendors.
- List knowledge and skills that help ensure success in clinical trials research settings.
Target Audience: Neuropsychologists, psychologists, advanced trainees in psychology, and other professionals interested in clinical trials research
NAN members login and non-members create an account to:
Instructional Level: Introductory to Intermediate (some prior knowledge of research terminology, typical scales used in clinical research, and neuropsychological constructs is expected)
Registration closes 30 minutes prior to the live presentation.
Robin C. Hilsabeck, Ph.D., ABPP
earned her Ph.D. in clinical psychology with a sub-specialization in neuropsychology from Louisiana State University. She completed an internship in clinical neuropsychology at University of Oklahoma Health Sciences Center and a 2-year postdoctoral fellowship in neuropsychology at University of California, San Diego Medical Center. Dr. Hilsabeck is a board certified clinical neuropsychologist who works at a large, global contract research organization, INC Research, as Senior Clinical Scientist in the CNS Business Unit. She is also Clinical Associate Professor in the Department of Psychology at University of Texas – Austin and maintains a small private practice. Prior to joining INC Research in 2012, Dr. Hilsabeck worked for 13 years in clinical, administrative, and academic research positions, most recently as Associate Professor of Psychiatry with tenure at University of Texas Health Science Center in San Antonio. Prior to that, she was Director of the Neuropsychology Residency Program and Neuropsychology Service at South Texas Veterans Health Care System in San Antonio. Dr. Hilsabeck currently serves as Associate Editor for The Clinical Neuropsychologist
and is on the editorial boards of Archives of Clinical Neuropsychology
and Neuropsychology Review
. She is Past President of the National Academy of Neuropsychology (NAN).
David Williamson, Ph.D., M.B.A.
holds a B.A. in Psychology from Duke University, received his graduate and post-doctoral training in Clinical Neuropsychology and Medical Psychology at the University of Florida and the University of Oklahoma Health Sciences Center, and obtained his MBA from LeBow School of Business of Drexel University. He is certified by the American Board of Clinical Neuropsychology, and he is a Fellow of the American Psychological Association and the National Academy of Neuropsychology. He has published in the areas of traumatic brain injury, ADHD, dementia, epilepsy, assessment of suicidality, and psychogenic nonepileptic seizures. He currently works as a Medical Science Liaison for Janssen Scientific Affairs, consults on issues of cognitive assessment in drug development and clinical trials, and is Adjunct Associate Professor in the Departments of Psychiatry and Neurology at the University of South Alabama. He serves as an ad hoc reviewer to Epilepsia
, the Archives of Clinical Neuropsychology
, the Journal of the International Neuropsychological Society
, Child Neuropsychology
, The Clinical Neuropsychologist
, and the Journal of Attention Disorders